|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
2 Laboratory of Physiology, Department of Marine Bioscience, Ocean Research Institute, University of Tokyo, Tokyo, Japan
3 Department of Integrative Physiology, University of Fukui, Fukui, Japan
* To whom correspondence should be addressed. E-mail: yoichi{at}med.uoeh-u.ac.jp.
We examined the effects of intracerebroventricular (icv) administration of adrenomedullin 2 (AM2) on plasma oxytocin (OXT) and arginine vasopressin (AVP) levels in conscious rats. Plasma OXT levels were markedly increased 5 min after icv administration of AM2 (1 nmol/rat) in comparison with vehicle and remained elevated in samples taken at 10, 15, 30 and 60 min. By contrast, plasma AVP levels were not significantly elevated in samples taken between 5-180 min after icv administration of AM2 except at the 30 min time point. Fos-like immunoreactivity (Fos-LI) was observed in various brain areas, including the paraventricular (PVN) and the supraoptic nuclei (SON) after icv administration of AM2 (2 nmol/rat) in conscious rats (measured at 90 min post-AM2 infusion). Dual immunostaining for OXT/Fos and AVP/Fos showed that OXT-LI neurons predominantly exhibited nuclear Fos-LI in comparison with AVP-LI neurons in the PVN and the SON. In situ hybridization histochemistry showed that icv administration of AM2 (0.2, 1 and 2 nmol/rat) caused marked induction of the expression of the c-fos gene in the PVN and the SON. This induction was significantly reduced by pretreatment with both the CGRP antagonist, CGRP8-37 (3 nmol/rat) and the AM receptor antagonist, AM22-52 (27 nmol/rat). These results suggest that centrally administered AM2 mainly activates OXT-secreting neurons in the PVN and the SON, at least in part through the CGRP and/or AM receptors with marked elevation of plasma OXT levels in conscious rats.
This article has been cited by other articles:
![]() |
M. Kawasaki, T. Onaka, M. Nakazato, J. Saito, T. Mera, H. Hashimoto, H. Fujihara, N. Okimoto, H. Ohnishi, T. Nakamura, et al. Centrally administered neuropeptide W-30 activates magnocellular neurosecretory cells in the supraoptic and paraventricular nuclei with neurosecretion in rats. J. Endocrinol., August 1, 2006; 190(2): 213 - 223. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |